File: '\\swfile\EmailIn\20260730 161203 Attachment News Release - MCTO.docx'

- 2 -

UniDoc Health Corp. Granted

Voluntary Management Cease Trade Order

VANCOUVER, British Columbia, July 30, 2026 -- UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) ("UniDoc" or the "Company") announces that it has been granted a voluntary management cease trade order in accordance with National Policy 12-203 ("NP 12-203"), due to it not being able to file its annual financial statements and management's discussion and analysis ("MD&A") for the year ended March 31, 2026 on SEDAR within 120 days of its financial year-end.

The Company concluded that it would not be in a position to complete the audit within the time periods required by National Instrument 51-102 ("NI 51-102") due to timing constraints in completing audit procedures. As a result, the Company requires additional time to file its annual financial statements and MD&A for the financial year ended March 31, 2026.

The Company expects to file its annual financial statements and MD&A for the year ended March 31, 2026 as soon as they are available, but in any event no later than September 27, 2026, and will issue a news release once they have been filed. The Company intends to satisfy the provisions of the alternative information guidelines of NP 12-203 by issuing bi-weekly default status reports, in the form of news releases, until the revocation of the management cease trade order. The Company is not subject to any insolvency proceedings. The management cease trade order will prohibit the Chief Executive Officer and the Chief Financial Officer of the Company from trading in securities of the Company for so long as the annual financial statements and MD&A are not filed. The issuance of the management cease trade order does not affect the ability of persons other than the Chief Executive Officer and the Chief Financial Officer of the Company to trade in the Company's securities.

On behalf of the Board of Directors,

Antonio Baldassarre

CEO, President & Director

UniDoc Health Corp.

About UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF)

UniDoc is developing eHealth solutions intended to support virtual clinical consultations through

remote healthcare points of service. The Company combines software, diagnostic devices and

communications tools so patients can access consultations from locations outside a physician's office. UniDoc's focus is physical access: helping governments, institutions and organizations deploy remote clinical access points for populations challenged by distance, access, technology use or care availability.

UniDoc is focused on building shareholder value through product deployment, commercialization and partnerships. More information is available at www.unidoctor.com.

For further information, please contact:

UniDoc Investor Relations

Tel: +1 778.383.6731

Email: info@unidoctor.com

Matt Chatterton, Director Tel: +1 778.613.2082

Email: matt@unidoctor.com

Media Inquiries media@unidoctor.com

Certain information contained herein constitutes "forward-looking information" under Canadian securities legislation. Forward-looking information includes, but is not limited to: the Company filing its annual financial statements and MD&A for the year ended March 31, 2026 as soon as they are available, and no later than September 27, 2026, and issuing a news release; and the Company satisfying the provisions of the alternative information guidelines of NP 12-203. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "anticipates", "anticipated" "expected" "intends" "will" or variations of such words and phrases or statements that certain actions, events or results "will" occur. Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made and they are from those expressed or implied by such forward-looking statements or forward-looking information subject to known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different, including receipt of all necessary regulatory approvals. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company will not update any forward-looking statements or forward-looking information that are incorporated by reference herein, except as required by applicable securities laws.

The CSE does not accept responsibility for the adequacy or accuracy of this release.